Denis Patrick

Denis Patrick Ph.D. is Vice President, Head of Partnering Innovation and Managing Partner of Pfizer Ventures. Denis capitalizes upon his experience in evaluating external opportunities that are focused on areas that complement Pfizer’s Research interests to identify, invest and manage equity investments. He is currently responsible for managing investments in AnTolRx, Encycle, eFFECTOR, MISSION Therapeutics, Metabomed, FoRx and EvolveImmune.

Denis previously engaged in oncology research and oncology licensing activities for several large pharma oncology organizations, including Merck, DuPont Pharma, GSK and Pfizer. Denis contributed significantly to several oncology drug discovery efforts that led to the approval of three marketed therapeutic agents including nelarabine, trametinib and dabrafenib. Denis also completed many licensing and acquisition agreements with large and small oncology focused biotech companies. Denis received his PhD in Biochemistry from the University of Pennsylvania.